Table 2. Molecular analysis of the 13 patients whose normal tissue, biopsy at diagnosis and surgical resection samples were analysed.

			TP53	D7S486	RB1	D9S171	D5S346	D5S492	Status
Patient 1	GR	Biopsy	h	h	AI	AI	h	h	CCR1
		Tumour	h	h	N	N	h	h
Patient 3	PR	Biopsy	h	AI	h	h	h	h	CCR1
		Tumour	h	N	h	h	h	h
Patient 4	GR	Biopsy	AI	N	AI	h	N	h	CCR1
		Tumour	AI	N	AI	h	N	h
Patient 6	PR	Biopsy	h	N	AI	AI	AI	h	CCR1
		Tumour	h	N	N	N	AI	h
Patient 8	PR	Biopsy	AI	N	AI	h	N	h	CCR1
		Tumour	AI	N	AI	h	N	h
		Metastasis	AI	N	AI	h	N	h
Patient 10	GR	Biopsy	AI	AI	AI	N	AI	h	CCR1
		Tumour	N	AI	N	N	AI	h
Patient 11	GR	Biopsy	AI	AI	AI	h	h	h	CCR1
		Tumour	N	N	N	h	h	h
Patient 16	PR	Biopsy	AI	h	N	AI	N	h	Dead
		Tumour	AI	h	N	AI	AI	h
Patient 27	PR	Biopsy	AI	N	N	h	N	N	CCR1
		Tumour	AI	N	N	h	N	N
Patient 29	GR	Biopsy	AI	AI	AI	AI	N	h	Dead
		Tumour	AI	AI	AI	AI	AI	h
Patient 47	PR	Biopsy	AI	AI	h	N	h	h	CCR1
		Tumour	AI	AI	h	AI	h	h
Patient 49	PR	Biopsy	AI	N	h	h	AI	AI	CCR1
		Tumour	N	N	h	h	N	AI
Patient 54	PR	Biopsy	AI	AI	h	AI	AI	h	Dead
		Tumour	AI	AI	h	AI	AI	h
		Relapse	AI	AI	h	AI	AI	h

The results were homozygous status (h), AI or normal status (N). This study involved GR and PR that were in first CCR1 or dead.